BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of marker genes starting with is 174
| GENE | HGNC_ID | CANCER_TYPE | HISTOLOGICAL_TYPE | CSC_ENRICHMENT | METHOD | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|
| KLF4 | 6348 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining and IF staining followed by SFA | 0.92 | 0.0891 | 32019273 |
| KLF4 | 6348 | Head and Neck Cancer | NA | NA | IHC staining followed by IF staining and SFA | 0.92 | 0.0891 | 32019273 |
| KLF4 | 6348 | Head and Neck Cancer | NA | NA | IF staining and SFA | 0.92 | 0.0891 | 32019273 |
| KLF4 | 6348 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.0891 | 30528285 |
| KLF4 | 6348 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.92 | 0.0891 | 19450560 |
| KLF4 | 6348 | Head and Neck Cancer | Cutaneous Squamous Cell Carcinoma | NA | IHC staining and IF staining followed by qRT-PCR | 0.92 | 0.0891 | 32850316 |
| KLF4 | 6348 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by Western Blotting | 0.92 | 0.0891 | 21292542 |
| MYC | 7553 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining and IF staining followed by SFA | 0.92 | 0.1304 | 32019273 |
| MYC | 7553 | Head and Neck Cancer | NA | NA | IHC staining followed by IF staining and SFA | 0.92 | 0.1304 | 32019273 |
| MYC | 7553 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IF staining | 0.92 | 0.1304 | 32327629 |
| MYC | 7553 | Head and Neck Cancer | NA | NA | IF staining and SFA | 0.92 | 0.1304 | 32019273 |
| MYC | 7553 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.1304 | 30528285 |
| MYC | 7553 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | qRT-PCR | 0.92 | 0.1304 | 20036608 |
| MYC | 7553 | Head and Neck Cancer | Cutaneous Squamous Cell Carcinoma | NA | IHC staining and IF staining followed by qRT-PCR | 0.92 | 0.1304 | 32850316 |
| MYC | 7553 | Head and Neck Cancer | Cutaneous Squamous Cell Carcinoma | NA | IF staining | 0.92 | 0.1304 | 32983794 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining and IF staining followed by SFA | 0.92 | 0.5461 | 32019273 |
| NANOG | 20857 | Head and Neck Cancer | NA | NA | IHC staining followed by IF staining and SFA | 0.92 | 0.5461 | 32019273 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR and Western Blotting | 0.92 | 0.5461 | 30651721 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IF staining | 0.92 | 0.5461 | 32327629 |
| NANOG | 20857 | Head and Neck Cancer | NA | NA | IF staining and SFA | 0.92 | 0.5461 | 32019273 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.5461 | 30528285 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by IHC staining | 0.92 | 0.5461 | 22640830 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | qRT-PCR | 0.92 | 0.5461 | 20036608 |
| NANOG | 20857 | Head and Neck Cancer | Hypopharyngeal Carcinoma | NA | qRT-PCR | 0.92 | 0.5461 | 23626764 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qPCR | 0.92 | 0.5461 | 23876835 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.92 | 0.5461 | 19450560 |
| NANOG | 20857 | Head and Neck Cancer | Cutaneous Squamous Cell Carcinoma | NA | IHC staining and IF staining followed by qRT-PCR | 0.92 | 0.5461 | 32850316 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by Western Blotting | 0.92 | 0.5461 | 21292542 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.5461 | 22847005 |
| NANOG | 20857 | Head and Neck Cancer | Squamous Cell Carcinoma | Cisplatin | SFA followed by qRT-PCR | 0.92 | 0.5461 | 32206093 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining and IF staining followed by SFA | 0.92 | 0.6448 | 32019273 |
| POU5F1 | 9221 | Head and Neck Cancer | NA | NA | IHC staining followed by IF staining and SFA | 0.92 | 0.6448 | 32019273 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qPCR and Western Blotting | 0.92 | 0.6448 | 23876835 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR and IF staining | 0.92 | 0.6448 | 22426199 |
| POU5F1 | 9221 | Head and Neck Cancer | NA | NA | IF staining and SFA | 0.92 | 0.6448 | 32019273 |
| POU5F1 | 9221 | Head and Neck Cancer | NA | NA | IHC staining | 0.92 | 0.6448 | 26556875 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.6448 | 30528285 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by IHC staining | 0.92 | 0.6448 | 22640830 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | qRT-PCR | 0.92 | 0.6448 | 20036608 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.92 | 0.6448 | 19450560 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.92 | 0.6448 | 22333601 |
| POU5F1 | 9221 | Head and Neck Cancer | Cutaneous Squamous Cell Carcinoma | NA | IHC staining and IF staining followed by qRT-PCR | 0.92 | 0.6448 | 32850316 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR and IF staining | 0.92 | 0.6448 | 21167769 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by Western Blotting | 0.92 | 0.6448 | 26239260 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by Western Blotting | 0.92 | 0.6448 | 21292542 |
| POU5F1 | 9221 | Head and Neck Cancer | Cutaneous Squamous Cell Carcinoma | NA | IF staining | 0.92 | 0.6448 | 32983794 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.6448 | 35140342 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.6448 | 22847005 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.6448 | 25871396 |
| POU5F1 | 9221 | Head and Neck Cancer | Squamous Cell Carcinoma | Cisplatin | SFA followed by qRT-PCR | 0.92 | 0.6448 | 32206093 |
| SOX2 | 11195 | Head and Neck Cancer | Cutaneous Squamous Cell Carcinoma | NA | IHC staining and IF staining followed by qRT-PCR | 0.92 | 0.5695 | 32850316 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining and IF staining followed by SFA | 0.92 | 0.5695 | 32019273 |
| SOX2 | 11195 | Head and Neck Cancer | NA | NA | IHC staining followed by IF staining and SFA | 0.92 | 0.5695 | 32019273 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qPCR and Western Blotting | 0.92 | 0.5695 | 23876835 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR and Western Blotting | 0.92 | 0.5695 | 30651721 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR and IF staining | 0.92 | 0.5695 | 21167769 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR and IF staining | 0.92 | 0.5695 | 22426199 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by Western Blotting | 0.92 | 0.5695 | 26239260 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IF staining | 0.92 | 0.5695 | 32327629 |
| SOX2 | 11195 | Head and Neck Cancer | NA | NA | IF staining and SFA | 0.92 | 0.5695 | 32019273 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.5695 | 35140342 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.5695 | 33513805 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.5695 | 22847005 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.5695 | 25871396 |
| SOX2 | 11195 | Head and Neck Cancer | NA | NA | IHC staining | 0.92 | 0.5695 | 26556875 |
| SOX2 | 11195 | Head and Neck Cancer | NA | NA | IHC staining | 0.92 | 0.5695 | 32816856 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.92 | 0.5695 | 30528285 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by IHC staining | 0.92 | 0.5695 | 22640830 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | qRT-PCR | 0.92 | 0.5695 | 20036608 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.92 | 0.5695 | 19450560 |
| SOX2 | 11195 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs | 0.92 | 0.5695 | 27619333 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | FACs followed by qRT-PCR and IF staining | 0.8 | 1 | 23627635 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR and Western Blotting | 0.8 | 1 | 30651721 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR and IF staining | 0.8 | 1 | 22426199 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs and IF staining | 0.8 | 1 | 22791367 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by Western Blotting | 0.8 | 1 | 22640830 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IF staining | 0.8 | 1 | 23563306 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IF staining | 0.8 | 1 | 32327629 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.8 | 1 | 35140342 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.8 | 1 | 22847005 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.8 | 1 | 27077749 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.8 | 1 | 26622836 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.8 | 1 | 25751671 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.8 | 1 | 21514878 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.8 | 1 | 23523931 |
| CD44 | 1681 | Head and Neck Cancer | Oropharyngeal Squamous Cell Carcinoma | NA | IHC staining | 0.8 | 1 | 24315751 |
| CD44 | 1681 | Head and Neck Cancer | NA | NA | IHC staining | 0.8 | 1 | 26556875 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.8 | 1 | 31811857 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.8 | 1 | 27619333 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.8 | 1 | 25320014 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | Cisplatin | SFA followed by qRT-PCR | 0.8 | 1 | 32206093 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.8 | 1 | 22333601 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | FACs | 0.8 | 1 | 26757432 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | FACs | 0.8 | 1 | 20073073 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | FACs | 0.8 | 1 | 22361100 |
| CD44 | 1681 | Head and Neck Cancer | NA | NA | FACs | 0.8 | 1 | 21322081 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | FACs followed by SFA | 0.8 | 1 | 19450560 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs | 0.8 | 1 | 26239260 |
| CD44 | 1681 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs | 0.8 | 1 | 23876835 |
| CTSB | 2527 | Head and Neck Cancer | Cutaneous Squamous Cell Carcinoma | NA | IF staining and Western Blotting | 0.68 | 0.0053 | 32983794 |
| CTSD | 2529 | Head and Neck Cancer | Cutaneous Squamous Cell Carcinoma | NA | IF staining and Western Blotting | 0.68 | 0.0053 | 32983794 |
| CTSG | 2532 | Head and Neck Cancer | Cutaneous Squamous Cell Carcinoma | NA | IF staining and Western Blotting | 0.68 | 0.0011 | 32983794 |
| NES | 7756 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | qRT-PCR | 0.6 | 0.0573 | 20036608 |
| NES | 7756 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.6 | 0.0573 | 19450560 |
| NES | 7756 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR and IF staining | 0.6 | 0.0573 | 21167769 |
| SHH | 10848 | Head and Neck Cancer | Squamous Cell Carcinoma | Cisplatin | SFA followed by IF staining and qRT-PCR | 0.6 | 0.0201 | 32206093 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs and IF staining | 0.52 | 0.684 | 22791367 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.52 | 0.684 | 35140342 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.52 | 0.684 | 26622836 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.52 | 0.684 | 25871396 |
| ALDH1A1 | 402 | Head and Neck Cancer | NA | NA | IHC staining | 0.52 | 0.684 | 26556875 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.52 | 0.684 | 31811857 |
| ALDH1A1 | 402 | Head and Neck Cancer | NA | NA | IHC staining | 0.52 | 0.684 | 32816856 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.52 | 0.684 | 25320014 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.52 | 0.684 | 22333601 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | ALDEFLUOR assay | 0.52 | 0.684 | 20073073 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | ALDEFLUOR assay | 0.52 | 0.684 | 22361100 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | ALDEFLUOR assay | 0.52 | 0.684 | 30067878 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | ALDEFLUOR assay | 0.52 | 0.684 | 27424180 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | ALDEFLUOR assay followed by SFA | 0.52 | 0.684 | 21292542 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | ALDEFLUOR assay followed by SFA | 0.52 | 0.684 | 24382806 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | ALDEFLUOR assay followed by Tumorigenicity assay and SFA | 0.52 | 0.684 | 19450560 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | ALDEFLUOR assay followed by Tumorigenicity assay and SFA | 0.52 | 0.684 | 20036608 |
| ALDH1A1 | 402 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | ALDEFLUOR assay followed by Tumorigenicity assay and SFA | 0.52 | 0.684 | 20936121 |
| BMI1 | 1066 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by Western Blotting | 0.36 | 0.1135 | 21292542 |
| BMI1 | 1066 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | Western Blotting | 0.36 | 0.1135 | 20036608 |
| BMI1 | 1066 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.36 | 0.1135 | 34689150 |
| BMI1 | 1066 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.36 | 0.1135 | 27619333 |
| BMI1 | 1066 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.36 | 0.1135 | 25320014 |
| BMI1 | 1066 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.36 | 0.1135 | 19450560 |
| S100A4 | 10494 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by Western Blotting | 0.36 | 0.0074 | 21169409 |
| ALDH1A2 | 15472 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.32 | 0.0117 | 24770634 |
| CD24 | 1645 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IF staining | 0.32 | 0.456 | 32327629 |
| CD24 | 1645 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.32 | 0.456 | 31811857 |
| CD24 | 1645 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.32 | 0.456 | 22333601 |
| CD24 | 1645 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | FACs followed by SFA | 0.32 | 0.456 | 19450560 |
| CD24 | 1645 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs | 0.32 | 0.456 | 27619333 |
| CXCR4 | 2561 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IF staining | 0.32 | 0.0498 | 23563306 |
| DCLK1 | 2700 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.32 | 0.0159 | 31706685 |
| DCLK1 | 2700 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.32 | 0.0159 | 28351564 |
| MET | 7029 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.32 | 0.0191 | 25320014 |
| MSI1 | 7330 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IF staining | 0.32 | 0.0201 | 32327629 |
| MSI1 | 7330 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | qRT-PCR | 0.32 | 0.0201 | 20036608 |
| NFE2L2 | 7782 | Head and Neck Cancer | Squamous Cell Carcinoma | Cisplatin | SFA followed by IF staining | 0.32 | 0.0042 | 32206093 |
| NGFR | 7809 | Head and Neck Cancer | Hypopharyngeal Carcinoma | NA | IHC staining | 0.32 | 0.018 | 23626764 |
| PROM1 | 9454 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IF staining | 0.32 | 0.7582 | 32327629 |
| PROM1 | 9454 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.32 | 0.7582 | 31811857 |
| PROM1 | 9454 | Head and Neck Cancer | NA | NA | MACs followed by SFA | 0.32 | 0.7582 | 22892238 |
| PROM1 | 9454 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by IF staining | 0.32 | 0.7582 | 27619333 |
| SKP2 | 10901 | Head and Neck Cancer | Carcinoma | NA | IHC staining | 0.32 | 0.0053 | 21352698 |
| SLC3A2 | 11026 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining | 0.32 | 0.0085 | 35140342 |
| SLC3A2 | 11026 | Head and Neck Cancer | Oropharyngeal Squamous Cell Carcinoma | NA | IHC staining | 0.32 | 0.0085 | 24315751 |
| SLC3A2 | 11026 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | IHC staining and Tumorigenicity assay | 0.32 | 0.0085 | 23523931 |
| ABCB1 | 40 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.28 | 0.0604 | 19450560 |
| ABCB1 | 40 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by RT-PCR | 0.28 | 0.0604 | 21292542 |
| ABCB5 | 46 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by RT-PCR | 0.28 | 0.0085 | 21292542 |
| ABCC1 | 51 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.28 | 0.0212 | 19450560 |
| ABCC2 | 53 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.28 | 0.0106 | 22426199 |
| ABCC2 | 53 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by RT-PCR | 0.28 | 0.0106 | 23876835 |
| ABCC5 | 56 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.28 | 0.0053 | 22426199 |
| ABCC6 | 57 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.28 | 0.0011 | 22426199 |
| ABCG2 | 74 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.28 | 0.1739 | 19450560 |
| ABCG2 | 74 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by RT-PCR | 0.28 | 0.1739 | 21292542 |
| ABCG2 | 74 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by RT-PCR | 0.28 | 0.1739 | 23876835 |
| GLI1 | 4317 | Head and Neck Cancer | Squamous Cell Carcinoma | Cisplatin | SFA followed by qRT-PCR | 0.28 | 0.0308 | 32206093 |
| ITGB1 | 6153 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.28 | 0.018 | 22333601 |
| ITGB1 | 6153 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs | 0.28 | 0.018 | 27619333 |
| KRT5 | 6442 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by qRT-PCR | 0.28 | 0.0064 | 21167769 |
| EPCAM | 11529 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs | 0.2 | 0.211 | 27619333 |
| ITGA2 | 6137 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs | 0.2 | 0.0106 | 27619333 |
| ITGA6 | 6142 | Head and Neck Cancer | Squamous Cell Carcinoma | NA | SFA followed by FACs | 0.2 | 0.0265 | 27619333 |
| LIN28A | 15986 | Head and Neck Cancer | NA | NA | FACs | 0.2 | 0.0138 | 21322081 |
| ZEB1 | 11642 | Head and Neck Cancer | NA | NA | SFA followed by FACs and SP assay | 0.2 | 0.0074 | 22892238 |
| ZEB2 | 14881 | Head and Neck Cancer | NA | NA | SFA followed by FACs and SP assay | 0.2 | 0.0021 | 22892238 |